Plasma concentrations during naltrexone implant treatment of opiate-dependent patients (Q35826348)

10 August 2017

Plasma concentrations during naltrexone implant treatment of opiate-dependent patients (English)

1 reference

10 August 2017

0 references

5

Jørg Mørland

1 reference

10 August 2017

Linda Olsen

1

1 reference

10 August 2017

Asbjørg S Christophersen

series ordinal

2

1 reference

10 August 2017

Grete Frogopsahl

series ordinal

3

1 reference

10 August 2017

Helge Waal

series ordinal

4

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

British Journal of Clinical Pharmacology

10 August 2017

1 reference

10 August 2017

58

1 reference

10 August 2017

2

1 reference

10 August 2017

219-222

1 reference

Depot naltrexone: long-lasting antagonism of the effects of heroin in humans

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884587

Clinical evaluation of a naltrexone sustained-release preparation

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884587

Implantable narcotic antagonists: a possible new treatment for narcotic addiction

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884587

Nontolerance to the opioid antagonism of naltrexone

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884587

Duration of occupancy of opiate receptors by naltrexone

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884587

Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884587

Serum naltrexone and 6-beta-naltrexol levels from naltrexone implants can block very large amounts of heroin: a report of two cases

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884587

Naltrexone treatment of heroin addiction: one-year follow-up.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884587

Naltrexone maintenance treatment for opioid dependence

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884587

Serum time course of naltrexone and 6β-naltrexol levels during long term treatment in drug addicts

15 November 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02122.X

The urinary excretion profile of naltrexone and metabolites in man

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15255807

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Naltrexone: disposition, metabolism, and effects after acute and chronic dosing

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15255807

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Determination of naltrexone and its major metabolite, 6-beta-naltrexol, in human plasma using liquid chromatography with electrochemical detection

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15255807

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.2004.02122.X

1 reference

10 August 2017

1 reference

10 August 2017

1 reference